Deinove (XPAR:ALDEI) FCF Margin % : -2,903.23% (As of Jun. 2022)

View and export this data going back to 2010. Start your Free Trial

What is Deinove FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Deinove's Free Cash Flow for the six months ended in Jun. 2022 was €-3.60 Mil. Deinove's Revenue for the six months ended in Jun. 2022 was €0.12 Mil. Therefore, Deinove's FCF Margin % for the quarter that ended in Jun. 2022 was -2,903.23%.

As of today, Deinove's current FCF Yield % is 0.00%.

The historical rank and industry rank for Deinove's FCF Margin % or its related term are showing as below:

XPAR:ALDEI' s FCF Margin % Range Over the Past 10 Years
Min: -3181.74 Med: 0 Max: 0
Current: -3181.74

XPAR:ALDEI's FCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -146.375 vs XPAR:ALDEI: -3181.74

Deinove FCF Margin % Historical Data

The historical data trend for Deinove's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Deinove FCF Margin % Chart

Deinove Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

FCF Margin %

Get a 7-Day Free Trial

-11,135.62

-28,579.49

-4,222.70

-1,534.06

-1,710.08

Deinove Semi-Annual Data
	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22
FCF Margin %	Get a 7-Day Free Trial															-788.44	-2,394.00	-980.08	-3,507.55	-2,903.23

Competitive Comparison of Deinove's FCF Margin %

For the Biotechnology subindustry, Deinove's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Deinove's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Deinove's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Deinove's FCF Margin % falls into.

Deinove FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Deinove's FCF Margin for the fiscal year that ended in Dec. 2021 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2021 )	/	Revenue (A: Dec. 2021 )
	=	-6.276	/	0.367
	=	-1,710.08 %

Deinove's FCF Margin for the quarter that ended in Jun. 2022 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jun. 2022 )	/	Revenue (Q: Jun. 2022 )
	=	-3.6	/	0.124
	=	-2,903.23 %

Deinove FCF Margin % Related Terms

Thank you for viewing the detailed overview of Deinove's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Deinove (XPAR:ALDEI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Deinove SA (XPAR:ALDEI) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1682 rue de la Valsiere, Cap Sigma, ZAC Euromedecine II, Grabels, FRA, 34790

Website

http://www.deinove.com

Deinove SA is a biotechnology company engaged in the development of technologies and molecules for the health, nutrition and cosmetics industries. It is developing in two areas of activity, New-generation anti-infective ANTIBIOTICS which involves the search for novel anti-infective molecules and the development of new generations of drugs capable of responding to the challenges of antibiotic resistance; and BIOACTIVES, natural active ingredients discovers, develops and produces bioactives, active ingredients of natural origin from its bacterial biodiversity bank, to invent the new generation of sustainable cosmetics and intends to quickly bring its know-how and its products to other fields, such as nutrition and health.

Deinove (XPAR:ALDEI) Headlines

No Headlines